Ironwood Pharmaceuticals (IRWD) Research & Development (2016 - 2025)
Historic Research & Development for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $22.5 million.
- Ironwood Pharmaceuticals' Research & Development fell 2467.23% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.7 million, marking a year-over-year decrease of 1893.25%. This contributed to the annual value of $111.4 million for FY2024, which is 401.77% down from last year.
- Latest data reveals that Ironwood Pharmaceuticals reported Research & Development of $22.5 million as of Q3 2025, which was down 2467.23% from $23.4 million recorded in Q2 2025.
- Over the past 5 years, Ironwood Pharmaceuticals' Research & Development peaked at $35.7 million during Q4 2023, and registered a low of $6.0 million during Q2 2023.
- Its 5-year average for Research & Development is $20.4 million, with a median of $22.5 million in 2025.
- In the last 5 years, Ironwood Pharmaceuticals' Research & Development plummeted by 6720.35% in 2022 and then surged by 40646.67% in 2024.
- Over the past 5 years, Ironwood Pharmaceuticals' Research & Development (Quarter) stood at $31.9 million in 2021, then crashed by 67.2% to $10.4 million in 2022, then surged by 241.53% to $35.7 million in 2023, then fell by 28.83% to $25.4 million in 2024, then dropped by 11.51% to $22.5 million in 2025.
- Its Research & Development stands at $22.5 million for Q3 2025, versus $23.4 million for Q2 2025 and $27.4 million for Q1 2025.